CHARLOTTE, N.C., June 17, 2008 (PRIME NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) appointed Joseph G. Oliveto to its management team, where he will serve as Vice President of Operations. With nearly 20 years of global pharmaceutical experience in the areas of licensing, project management, clinical development and manufacturing, Mr. Oliveto will be responsible for overseeing key areas of the company’s day-to-day operations, providing leadership for project management, manufacturing, and operational aspects of commercialization activity for Droxidopa.
